Speeches by Bryant.
Every Hansard contribution by Chris Bryant this parliament, most recent first. Back to the MP page for the headline figures and analysed positions.
Showing 1,661–1,680 of 2,063 contributions · most-recent first
| Date | Debate & contribution | Words |
|---|---|---|
| 12 Feb 2025 | Data (Use and Access) Bill [Lords] “rose—” technologyeconomy-jobs | 1 |
| 12 Feb 2025 | Animal Testing “I cannot provide the hon. Gentleman with that timeline now. We are working at pace trying to put together a practicable policy and a strategy which, as I said, we will publish by the end of the year. He makes a perfectly good point about the complexities. It will not be easy for the MHRA to meet its international commi…” healthtechnology | 95 |
| 12 Feb 2025 | Animal Testing “I did not know that my hon. Friend had taken over the APPG; it is a good thing that it exists. We will work very closely with the APPG. Whether I am the right Minister or whether there is a more intelligent Minister—or a more charming one, perhaps—who might be of more assistance to her, I will make sure that she gets a…” healthtechnology | 68 |
| 12 Feb 2025 | Animal Testing “Our aim is to phase out animal testing as soon as is practicable. We have been working closely, and it was a manifesto commitment of ours. We have been meeting scientists and other Departments, because this area is not the sole responsibility of the Department for Science, Innovation and Technology. We intend to publis…” healthtechnology | 69 |
| 12 Feb 2025 | Innovation: Livingston “Livingston is a remarkable example of where investment can make a significant difference. I am really pleased that the chief executive of SilviBio recently received a women in innovation award for innovation in science. My hon. Friend is absolutely right that innovation accelerator projects in Glasgow and across the wh…” technologyeconomy-jobslocal-government | 101 |
| 12 Feb 2025 | Innovation: Livingston “We have already spent £4 million on projects in my hon. Friend’s constituency, including £88,000 on SilviBio Ltd. I am very proud of the fact that we have been able to commit, in 2025-26, to a record amount of money—£20.4 billion—for research and development.” technologyeconomy-jobslocal-government | 44 |
| 12 Feb 2025 | Data (Use and Access) Bill [Lords] “Oh dear, she is. I am not sure about having world-class rugby players on the Committee, but it is one of the issues I am very happy to debate with my hon. Friend. We want to make sure we have got it right and that we manage to embrace everybody as much as we can.” technologyeconomy-jobs | 55 |
| 12 Feb 2025 | Data (Use and Access) Bill [Lords] “I think it might be easier if I respond to that now. Yes, I completely and utterly agree with the right hon. Gentleman. That is our settled view. We want to get to a process where there is more licensing of content, and we have said that repeatedly. It is one of the aims of our consultation. He says that copyright does…” technologyeconomy-jobs | 94 |
| 12 Feb 2025 | Data (Use and Access) Bill [Lords] “No, it is not. What is true is that, as I said, we want to get to a concrete idea of what transparency might look like. Not enough work has been done in the EU or in different territories—in the United States of America, for instance, where different states have different arrangements—and we need to do more about what …” technologyeconomy-jobs | 173 |
| 12 Feb 2025 | Data (Use and Access) Bill [Lords] “I will in a moment. That is why I am keen on not selling the pass on that possibility by having undermined it before we get there.” technologyeconomy-jobs | 27 |
| 3 Feb 2025 | AstraZeneca “I could read out the long list of investments made in the last few months, except I do not think that Mr Speaker would let me. I do not think we have time, and you would get bored with me, Mr Speaker. The hon. Member makes an important point. At the moment, I am engaged in negotiations on a significant possible investm…” economy-jobstechnology | 239 |
| 3 Feb 2025 | AstraZeneca “First, let me clear up a point about national insurance contributions. I know that the Conservative party likes to bang on about them, but many people do not know that 50% of businesses and organisations in the UK will pay either exactly the same amount of national insurance or less. That fact is not often, if ever, re…” economy-jobstechnology | 102 |
| 3 Feb 2025 | AstraZeneca “It is almost sad, sometimes. I just wish the hon. Member had been here for the last 14 years. I wish he had been here when we had endless strikes in every single part of every Department and we could not get the NHS waiting lists dealt with because we were not paying our nurses and our doctors properly. The first thing…” economy-jobstechnology | 120 |
| 3 Feb 2025 | AstraZeneca “I think the hon. Gentleman needs to speak to the hon. Member who spoke earlier—oh, he’s left. I actually believe that the vaccines saved lives; I do not believe that they lost people their lives. I am afraid that the hon. Gentleman and I will never be united on that front.” economy-jobstechnology | 51 |
| 3 Feb 2025 | AstraZeneca “Some of what I have already pointed out is really important. We have already said that we will have the lowest corporation tax rate in the G7, at 25%, and we are sticking with that. We have made sure that we are investing in our public services so that people can have a guarantee of proper public services in this count…” economy-jobstechnology | 141 |
| 3 Feb 2025 | AstraZeneca “It does not send any kind of message like that. The point is that in the UK we have secured dramatic amounts of additional investment since the general election. What is interesting is that all the Conservative Members are praising something that was never delivered by the previous Government; it was only announced. It…” economy-jobstechnology | 122 |
| 3 Feb 2025 | AstraZeneca “If I might just refer to the first comment first, I am the Member for Rhondda and Ogmore, so I fully understand that investment in one part of the country is obviously great for that part of the country, but it does not necessarily mean that every part of the country is rising with everybody else. Trying to make sure t…” economy-jobstechnology | 162 |
| 3 Feb 2025 | AstraZeneca “The hon. Lady’s first point was on the voluntary scheme for branded medicines pricing and access, which is reduced to an acronym that is not really an acronym: VPAG. This is, as it says on the tin, a voluntary agreement between Government, the pharmaceutical industry and the NHS, which is designed specifically to ensur…” economy-jobstechnology | 184 |
| 3 Feb 2025 | AstraZeneca “I would be delighted to meet my hon. Friend knows, as she knows, although I think it would probably be more useful for her if she were to meet Lord Vallance, who is the Minister for life sciences. My hon. Friend is absolutely right; we would of course much prefer this investment to go ahead and to have been able to get…” economy-jobstechnology | 113 |
| 3 Feb 2025 | AstraZeneca “Not necessarily for this specific deal, but certainly for a deal with AstraZeneca, yes.” economy-jobstechnology | 14 |